Log In
Print
BCIQ
Print
Print this Print this
 

Naloxegol (formerly NKTR-118)

  Manage Alerts
Collapse Summary General Information
Company Nektar Therapeutics
DescriptionPEGylated form of naloxol, a peripheral mu opioid receptor (OPRM1; MOR) antagonist
Molecular Target Mu opioid receptor (OPRM1) (MOR)
Mechanism of ActionOpioid receptor antagonist
Latest Stage of DevelopmentPhase III
IndicationConstipation
Partner

AstraZeneca plc
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today